The JNK Inhibitor XG-102 Protects from Ischemic Damage with Delayed Intravenous Administration Also in the Presence of Recombinant Tissue Plasminogen Activator
Year: 2008
Type: article
Source: Cerebrovascular Diseases
DOI: 10.1159/000151639
Institutions: Centre Hospitalier Universitaire Vaudois, Xigen (Switzerland)
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2015182670
